MapLight Therapeutics, Inc. (MPLT)
18.12
+0.26
(+1.46%)
USD |
NASDAQ |
Dec 24, 16:00
MapLight Therapeutics EPS Diluted (Quarterly): -0.6484 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CDT Equity, Inc. | -13.16 |
| LENZ Therapeutics, Inc. | -0.5851 |
| Liminatus Pharma, Inc. | -0.0675 |
| Oruka Therapeutics, Inc. | -0.6871 |
| Maze Therapeutics, Inc. | -0.6258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.42M |
| Total Expenses (Quarterly) | 29.42M |
| Enterprise Value | 1.109B |